Launched in 1985, Options for the Control of Influenza
has grown into the largest international conference devoted exclusively
to influenza, covering every imaginable topic from basic science to
health care policy.
Whatever your domain of expertise – science, human medicine, animal
medicine, public health policy, industry or media – Options
for the Control of Influenza VII will provide
comprehensive scientific guidance for all disciplines involved in
influenza prevention, control and treatment, including seasonal and
pandemic planning. On behalf of the conference chairs, Professor Malik Peiris, Dept of
Microbiology, University of Hong Kong and and Scientific
Director HKU-Pasteur Research Center, and Professor Yi Guan, Dept of
Microbiology, University of Hong Kong and Director of State Key
Laboratory of Emerging Infectious Diseases, we invite you to attend in
the Options for the Control of Influenza VII conference
The Options conference series is held approximately every
three years and is the largest meeting that brings together scientists
working on all aspects of influenza, from basic science to healthcare
policy.
Options for the Control of Influenza will celebrate its
25-year anniversary since its inception and first meeting in Keystone,
Colorado in 1985. The influenza situation today is far more complex and
demanding with the advent of the first pandemic declared in 25 years. Options
has a history of strong scientific content and the 2010 meeting will
continue this tradition of answering the call for the latest scientific
information on ALL aspects of influenza. Plan to attend all four days
and experience the spectacular scientific and cultural program. This
year`s schedule will begin on Friday 3 September at 0900.00 with an
exciting opening ceremony celebrating 25 years of the Options for the
Control of Influenza conference series.
Due to the recent declaration of the influenza pandemic and the space
constraints at the HKECE, the 2010 meeting will be limited to no more
than 1200 attendees, so we urge you to please register early.
The goal of Options VII is to showcase recent advances in
the basic science and control and prevention of influenza. At the same
time, we invite all of the attendees to experience the heritage and
cultural diversity of Hong Kong. Hong Kong is a unique fusion of Eastern
and Western cultures where the old and the new live side by side. Hong
Kong combines gourmet culinary delights, renowned cultural activities, a
shopper’s paradise, and the latest technological advances.
We invite you to come early and stay over after the meeting to take in
the many wonders of the city. We look forward to seeing you in Hong
Kong!
For 50 years, ICAAC has presented science of the highest scientific
quality with an international focus and late-breaking information. More
than 10,000 physicians, researchers and other healthcare professionals
from around the globe will gather at the 50th ICAAC to foster worldwide
solutions to the problem of infectious disease. To enrich the attendee
experience, the ICAAC Program Committee will select faculty that
includes internationally renowned scientists and will complement the
invited program with slide and poster abstract presentations. The 50th
ICAAC is expected to be another successful educational event and an
opportunity to exchange the latest information with scientists from
around the world.
On behalf of the Federation of European
Microbiological Societies (FEMS) and the European Society of Clinical
Microbiology and Infectious Diseases (ESCMID), we have the privilege to
announce the 6th Conference on New Frontiers in Microbiology and
Infection. These annual conferences are intended to become outstanding
events in the field of microbiology and to meet the following
objectives:
to transfer knowledge between basic and clinical microbiologists as well as infectious diseases specialists
to
focus and determine the state of the art on a particular field or theme
by bringing together the best European and non-European scientists
to give young scientists the opportunity to interact with senior scientists
To
stimulate and optimize the interactions, the conferences will include
about 15 outstanding invited speakers together with only 60
participants selected on the basis of their scientific work and their
interest in the chosen topic. Grants will be available to help
participants with financial difficulties.
The 2010 edition is entitled "Salmonella"
and will be held in Villars-sur-Ollon, a nice and peaceful resort in
the Swiss mountains. We encourage you to join this event and to submit
an abstract of your work.
The program as well as deadlines for abstract
submission, application and registration will be on the conference
website by the end of March.
We are looking forward to meeting you in Villars-sur-Ollon.
Robert Read and Jordi Vila ESCMID Conference Coordinators
Roland Koerner and Jean-Claude Piffaretti FEMS Conference Coordinators
The 3rd Access to Healthcare in Africa Conference will bring together leaders in
the fight against the Big Three diseases: HIV/AIDS, TB and Malaria. This year’s
principal topic will be the various implications of changing treatment
guidelines and the symposium is scheduled to take place 06 & 07 October 2010
in Johannesburg - South Africa.
The 48th Annual Meeting of IDSA will be held October 21 – 24, 2010 at the Vancouver Convention and Exhibition Centre, Vancouver, British Columbia, Canada.
The meeting brings together physicians, scientists, and other health care professionals involved in research, patient care, public health, disease prevention, and education in the field of infectious diseases. There are no prerequisites for attendance. This meeting provides three and a half days of broad continuing educational courses and comprehensive educational experiences in the major facets of infectious diseases: pathophysiology, diagnosis, treatment, and prevention. The courses combine expert reviews of the traditional field of infectious diseases with emphasis on the most contemporary trends, including emerging infections, new diagnostics, vaccines, and therapeutics.
Conference Objectives
To update infectious diseases clinicians and investigators with state-of-the-art developments in the field, including timely reviews of recent advances in clinical care and research and original reports of clinical, translational, and basic research
To bridge the widening gaps among the fields of infectious diseases clinical practice, clinical research, epidemiological and health services research, translational research, and basic research
To promote multi-disciplinary dialogue and collaboration among clinicians and investigators, thus facilitating advances in the prevention, diagnosis, and treatment of infectious diseases
World Influenza Congress Europe is the annual influenza conference addressing every aspect of influenza policy and planning, influenza research & development, and stakeholder partnerships.
As an addition to an already globally recognised World Vaccine Congress series, World Influenza Congress Europe is positioned as Europe`s largest and most influential Influenza vaccine event.
The Infectious Disease Seminar is designed to provide practical, cutting-edge information to practicing physicians, pharmacists nd other healthcare professionals concerning evaluation and management of infectious diseases. Case discussions will be used extensively. Those attending the conference will be able to:
Review the latest medical and pharmaceutical advances in treating infectious diseases, which impact physicians, pharmacists and other healthcare professionals.
Evaluate treatment options for a wide variety of infectious diseases, including the role of newer pharmacological agents on the market.
Learning objectives for each specifc topic will be mailed to those who pre-register along with a letter confrming receipt of your registration materials.
The aim of this two days symposium is to review current concepts, technology and present advances in infections in the critically ill patients.
Sepsis, Pulmonary Infections, Basic Research, Pulmonary Infections Treatment and Prophylaxis Therapy of severe infections will be the topics of the main sessions presented by experts who will review and update the new advances on infections in the critically ill patient. At the end of each session a Clinical Controversy, Pannel Discussion or Case Report Discussion will be organized.
Presented by the Department of
Medicine, Division of Infectious Diseases, at the University of
California, San Francisco School of Medicine, this course reviews
clinically relevant topics in infectious diseases which are chosen
because they are of interest to the practicing clinician or because
there have been significant recent advances in diagnosis or treatment.
Target Audience:
The course is designed to meet the needs of a variety of clinicians,
including primary care physicians, family physicians, general
practitioners, hospitalists, internists, nurse practitioners,
pediatricians, clinical pharmacists, and other health professionals who
are involved with infectious diseases in the inpatient or outpatient
settings.
Participants attending this conference will learn about the
microbiological aspects, pathophysiology and clinical presentations of
common and emerging invasive fungal infections. Up-to-date information
on diagnosis and treatment for these infections will also be discussed
in detail and future prospects will be highlighted.
Target Audience
Specialists or physicians in training in the
following disciplines: infectious diseases, clinical microbiology,
mycology, other disciplines dealing with immunocompromised patients
(e.g. haematology, oncology, chest medicine).
Emerging infectious disease, Tropical dermatology, Fever in the
returned traveller, Altitude Illness, Malaria epidemiology and
pathogenesis, Marine hazards/envenomations, 3 interactive / case based
sessions
TROPICAL MEDICINE
Malaria prevention for the traveller, Malaria management and treatment
in the returning nonimmune traveler, Rabies and the international
traveller, Travellers` Diarrhea, Leishmaniasis in returning travelers,
Viral hemorrhagic fever and Bioterrorism, 3 interactive / case based
sessions
INFECTIOUS DISEASES
Update on HIV treatment, HIV transmission & prevention ( post
exposure prophylaxis, microbicides, circumcision etc), Treatment of
bacterial STD’s & STD syndromes, Influenza: Pigs, birds, and
people, Antibiotic resistant bacteria in the community, Genital herpes:
transmission and treatment, 3 interactive / case based sessions
MEDICAL LEGAL
Principals and ethical pitfalls of medical legal assessments , How to succeed as an expert witness in court
This meeting will provide an update on phenotypic and functional aspects of regulatory T cells, aiming to inform, educate and entertain. Presentations will be delivered by world-class leaders in their respective fields and a lively discussion will follow each series of talks. Coupled with the pleasant ambience and modern facilities of the venue, this event promises to be one not to be missed" Meeting Chair: Dr Oliver Garden ,The Royal Veterinary College & Imperial College London, UK
Following this course, the participant should be able to recognize the epidemiology and classify commonly presenting infectious diseases; identify the clinical manifestations, pathogenesis and methods of diagnosing the presenting diseases; and apply the current recommendations of pharmacologic management, referral or follow-up and prevention. This activity is expected to result in increased confidence in making an appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes.
The emphasis will be on current guidelines and evidence-based medicine, as indicated within each topic’s specific objectives. Since Infectious Diseases is a specialty field of medicine that affects all areas of Primary Care to include: FM, IM, EM and Pediatrics, this course was designed to cover the spectrum of Infectious Diseases essential to all practicing physicians.
This educational activity is designed for medical oncologists,
infectious disease specialists, hematologists, hospitalists, and other
physicians, physicians-in-training, and healthcare professionals
interested and/or involved in the care of patients with febrile
neutropenia.
Objectives
Upon completion of this activity, participants should be able to:
Discuss
and evaluate the clinical use of prophylactic versus empiric or
preemptive therapy of fungal infections in febrile neutropenic patients
Discuss the appropriate selection and practical
utilization of replacement antibiotics for therapy of infections caused
by resistant bacteria in febrile neutropenic patients
Describe the role of native immunity on susceptibility and severity of infection in patients with febrile neutropenia
Identify
and assess management strategies for infections in patients undergoing
stem cell transplant from alternative sources and donors
Compare current and emerging therapies in the prevention and management of patients with febrile neutropenia
ISPPD-7 will bring together top researchers and clinicians from around the world for a fascinating program highlighting the latest scientific achievements in the many aspects related to pneumococci and pneumococcal diseases.
Topics will cover epidemiology, pathogenic mechanisms, clinical aspects, prevention and treatment. Set in Tel Aviv along the beautiful Mediterranean coastline, participants will get a chance to experience the unique cultural and energetic atmosphere of this metropolitan city.
Symposia Topics
Interaction of S. pneumoniae with other viral and bacterial agents
Worldwide application of pneumococcal vaccines
Serotype dynamics pre vs. post vaccination
Pneumonia and other respiratory pneumococcal infections
Constituents of immune protection
Pneumococcal evolution
Novel pneumococcal vaccines and alternative vaccination strategies: from bench to clinical trials
Treatment controversies
Man and pneumococcus - les liaisons dangereuses
The symposium will bring together researchers and clinicians from all
over the world who are interested in the many aspects of pneumococci
and pneumococcal diseases. The stimulating scientific program will
highlight the latest scientific achievements, enhance existing
knowledge and lead to improved diagnosis, prevention and treatment.
Topics will cover epidemiology, bacteriology, pathogenic mechanisms,
clinical aspects, prevention and treatment. The program will include
state-of-the-art plenary lectures, selected presentations from
submitted abstracts and ample opportunity will be provided for
interactive discussions.
Nuclear receptors represent a family
of ligand-regulated transcription factors that play central roles in
development, physiology, and metabolism. Upon binding small lipophilic
hormones and metabolites, such as steroids, fatty acids, and bile
acids, nuclear receptors switch their regulatory status, reprogramming
gene expression in target tissues. Current research is aimed at
defining roles for these receptors in normal development and metabolism
as well as better understanding how nuclear receptor dysfunction
contributes to diabetes, cancer, cardiovascular disease, obesity, and
neuronal disorders. Nuclear receptors are also a major target for drug
development, with many compounds on the market and several in ongoing
human trials. This meeting will highlight recent breakthroughs in
nuclear receptor research, promote interactions between scientists from
industry and academia, and provide opportunities for senior scientists
to interact with younger researchers and trainees.
It is our great pleasure to welcome you to the 4th European Virology Congress (EVC) in Cernobbio, lake of Como, IT, April 7-11, 2010 (www.eurovirology2010.org). The congress will be the annual meeting of the European Society for Clinical Virology, the German/Swiss/Austrian Society for Virology (Gesellschaft fϋr Virologie) and the Italian Society of Virology.
The Eurovirology Congresses, renamed European Virology Congresses, were initiated in 2000 to bring together young and senior investigators from all Countries of Europe and from all branches of Virology. The aim was to strengthen Virology in Europe, by providing a platform for basic, medical, clinical, veterinary, and plant Virology. Congresses were held sequentially in UK, Spain and Germany. Importantly, they have fostered the foundation of the European Society for Virology (www.eusv.eu), the inaugural meeting of which will be held in Rome, April 24, 2009.
The Venue is the beautiful Spazio Congressi Villa Erba, Cernobbio, Lake of Como. This is one of Italy`s most enchanting corners. Cernobbio, very close to Como, dominates the west side of the lake and offers a breathtaking view of miles of the lake. Lake Como has always been and still is a world famous international resort. Visitors are enraptured by its charming atmosphere and natural beauty. Cernobbio-Como are 50 Km away from the Malpensa Airport, the main airport in Northern Italy.
Together, with advice from the Scientific Advisory Committee, we have endeavoured to put together an exciting and informative program that covers the many facets of virology.
We sincerely thank you for your participation and hope that you find the science and the beautiful location stimulating and enjoyable.
Reagrds,
Gabriella Campadelli-Fiume Carlo De Giuli Morghen Giorgio Palù
The Infectious Disease Seminar is designed to provide practical, cutting-edge information to practicing physicians, pharmacists and other healthcare professionals concerning evaluation and management of infectious diseases. Case discussions will be used extensively. Those attending the conference will be able to:
Review the latest medical and pharmaceutical advances in treating infectious diseases, which impact physicians, pharmacists and other healthcare professionals;
Evaluate treatment options for a wide variety of infectious diseases, including the role of newer pharmacological agents on the market.
Learning objectives for each specific topic will be mailed to those who pre-register along with a letter confirming receipt of your registration materials.
It gives us great pleasure to invite you to this important event
organized by the European Society of Clinical Microbiology and
Infectious Diseases (ESCMID).
In the 20 years since its inauguration, ECCMID has steadily grown
in importance. Its meetings provide a unique opportunity for
participants to interact, learn and impart knowledge in the areas of
antimicrobial chemotherapy and infectious diseases which play such an
important role in medicine in Europe and other parts of the world.
During the congress an industrial exhibition will be arranged.
Companies from all over the world will be given ample opportunity to
display their latest products, services and technical innovations.
The high-standard scientific programme, which runs over four full
days, consists of keynote lectures and parallel tracks, offering you
the opportunity to hear about the latest advances in clinical
microbiology and infectious diseases. Stimulating presentations on the
latest research findings in laboratory and clinical diagnosis, therapy
and prevention of infectious diseases will be addressed in a truly
interdisciplinary way. The list of invited speakers contains a high
number of international leaders in their field. In addition, your
contributions will be displayed in a poster exhibition that will
undoubtedly generate lively discussions.
Program Purpose / Objectives
To recognize and diagnose emerging, evolving and less common infectious diseases. Preliminary Topics for Activity
1. Review common disorders including community acquired pneumonia, acute gastroenteritis and MRSA skin infections 2. Ethical issues in infectious disease 3. Public health responsiblities
In 2010 ESCMID will celebrate once again the International Day for Fighting Infection by organizing a one-day symposium on milestones in the history of infections. This 3rd edition will be held once again on St. George`s Day and will trace the evolution over the centuries of infection control in hospitals and of ad-hoc hospitals for infectious patients.
This event is organized in cooperation with the International Society of Chemotherapy (ISC) and the International Society of Infectious Diseases (ISID), and supported by The Lancet Infectious Diseases.
The European Society for Paediatric Infectious Diseases Annual Meetings are held annually guaranteeing attendees the most up to date information on epidemiology, diagnosis, prevention, treatment, and clinical presentation of important paediatric diseases. ESPID 2010, co-organized by the ESPID Society and the ESPID Foundation, features international experts, a high-quality scientific program, and the beautiful city of Nice as its 28th meeting location
This exciting meeting will cover a broad array of cutting edge topics in infectious diseases (not only tropical medicine!). The invited international speakers will present key insights into malaria, vaccinology, and microbial genomics. Other sessions will cover topics including viral hepatitis, mycobacterial disease, infections in intensive care, clinical trials in infectious diseases and much more.
The conference will provide a
unique opportunity to participate in hearing
or presenting the latest information in the
field of travel medicine. The target audience
includes travel medicine practitioners, primary care
physicians, infectious disease and tropical medicine
specialists, researchers, nurses,
pharmacists, and students involved in this
field. The conference will also meet the needs of the
travel media and industry including manufacturers of travel
health-related products, drugs and vaccines.
The programme will include all aspects of travel
medicine including the “basics“ such as
vaccinations, malaria prophylaxis and
travellers diarrhoea – but we will also try to substantiate
travel medicine advice on a sound scientific basis and on
good epidemiological data. In our opinion, travel medicine in
a globalised world also includes migration medicine,
occupational medicine and environmental
issues. Practitioners giving pre-travel
advice also see patients returning with unfamiliar
and tropical diseases – differential diagnosis in these
travellers will also be an important topic. A
special local conference theme will be
maritime medicine. Last but not least we think
that the conference is a forum to establish standards for
training and education in travel medicine.
7-Night Alaska Cruise Conference from SeattleWashington
The purpose of this CME activity is to outline the management of infectious challenges in clinical practice including emerging infections and antibiotic/preventive choices.
“At the conclusion of this CME activity, participants should be able to: • Define risk factors for complicated UTIs • Discuss the new vaccination recommendations for 2010 • Outline the CDC prevention guidelines for STDs • Identify the risks of inappropriately timed vaccine delivery • Discuss the increasing need for antiviral agents in the US today • Recognize the increasing significance of fungal infections • Outline three options for treating GAS carriers • Describe emerging resistance to problem pathogens • Summarize the guidelines for managing community-acquired pneumonia • Review the history of MRSA • List the characteristics of MSRA, the new C diff strain and SARS • Identify ways to approach children with rashes
Ditan International Conference on Infectious Diseases is the annual conference holding in Beijing to provide platform for scientific exchange between Chinese and international experts. It is co-organized by Beijing Ditan Hospital, European Society of Clinical Microbiology and Infectious Diseases, ESCMID and Global Chinese Association of Clinical Microbiology and Infectious Diseases, GCACMID.
Globalization has increased the spread of infectious diseases, modern modes of transportation allow more people and products to travel around the world at a faster pace; they also open the airways to the transcontinental movement of infectious disease vectors. We also know that it is important to target and reduce the spread of infectious diseases in developing countries.
As the largest developing country, China is playing an important role in the control of the infectious diseases. Ditan Hospital as the major hospital of infectious diseases in China, has taken the responsibility to link up the Chinese medical community with the international and organized this annual conference for timely communication.
Renowned experts are invited to the conference to share their experience and research findings. At the same time, participants can obtain the updated information from China and the rest of the World.
Focus on China, Impact on the World!
Mission & Objective The mission of DICID is to serve as a platform for timely communication between Chinese and international professionals in order to control the spread of infectious diseases effectively. There are three objectives:
To provide the fundamental knowledge and essential updates of infectious diseases to the health care professionals with a dynamic program covered scientific research, clinical practice and administration strategy.
To allow international colleagues having a clearer picture of China.
To enhance the development of young investigators.
The pandemic of avian H1N1 influenza has, so far, presented enormous challenges to healthcare professionals and researchers worldwide. Many countries have just come through their first wave of H1N1 influenza; others still have yet to face it. However, this novel and unpredictable virus will surely continue to threat the public health in the future.Therefore, it is of the upmost urgency that we share what we have learnt thus far and decide how we can use this knowledge to prepare for and combat the disease in the future. This two-day forum, hosted by China CDC and co-organized by Elsevier, brings together leaders in the field of health from all over the world, with experts from WHO, the US CDC, European CDC, and other leading healthcare institutions.
Important
Due to possible changes in conference details, we recommend that you check with the conference
website, before making any traveling arrangements.
* Prices are for evaluation only. For accurate prices, please check with conference website.
